Abstract The leptin-deficient ob/ob mice are insulin resistant and obese. However, the control of blood pressure in this model is not well defined. The goal of this study was to evaluate the role of leptin and of the renin-angiotensin system in the cardiovascular abnormalities observed in obesity using a model lacking leptin. To this purpose, we measured blood pressure in ob/ob and control animals by radiotelemetry combined with fast Fourier transformation before and after both leptin and enalapril treatment. Autonomic function was assessed pharmacologically. Blood pressure during daytime was slightly higher in the ob/ob compared to control mice, while no difference in heart rate was observed. Blood pressure response to trimetaphane and heart rate response to metoprolol were greater in ob/ob mice than in control littermates indicating an activated sympathetic nervous system. Heart rate response to atropine was attenuated. Baroreflex sensitivity and heart rate variability were blunted in ob/ob mice, while low frequency of systolic blood pressure variability was found increased. Chronic leptin replacement reduced blood pressure and reversed the impaired autonomic function observed in ob/ob mice. Inhibition of angiotensinconverting enzyme by enalapril treatment had similar effects, prior to the loss of weight. These findings suggest that the renin-angiotensin system is involved in the autonomic dysfunction caused by the lack of leptin in ob/ ob mice and support a role of this interplay in the pathogenesis of obesity, hypertension, and metabolic syndrome.
Introduction
Obesity, hypertension, dyslipidemia, and diabetes type II are the main risk factors which characterize metabolic syndrome when present simultaneously [1] . In an attempt to correlate obesity, diabetes type II, and hypertension, Landsberg postulated an interesting model in which blood pressure (BP) increase is thought to be an unfortunate result of mechanisms that establish energy balance and limit weight gain. Although compelling evidences tightly correlated these diseases, no adipose tissue-derived molecule was taken into account [2] . In fact, obesity itself can activate the sympathetic and the renin-angiotensin system, resulting in BP increase [3] . It is well described that both rodents and humans with obesity have higher levels of leptin [4] , an important hormone expressed and secreted by adipose tissue proportionally to its size [5] . Leptin acting centrally [6] decreases body weight and adipose tissue mass through inhibiting appetite and food intake [7] . Moreover, intracerebroventricular administration of leptin increases renal sympathetic nerve activation and arterial pressure [6] . However, we have recently shown that the leptin receptordeficient db/db mice had higher BP compared to control littermates, which was unexpectedly associated with increased sympathetic and attenuated parasympathetic drive [8] , characterizing a cardiovascular autonomic dysfunction observed in obesity. In addition, since enalapril normalized the autonomic dysfunction in db/db mice, angiotensin II may be involved. This peptide regulates BP through actions in peripheral tissues and in the brain by activating the sympathetic nervous system [9] and altering baroreflex heart rate (HR) regulation [10] . Db/db mice only lack one type of leptin receptor and may still be responsive to this hormone. Thus, it could not be excluded that the high circulating leptin levels in db/db mice could be involved in the sympathetic activation and increased BP in this model. To finally clarify the role of leptin and its relation to angiotensin II, we studied a model lacking leptin. Measurement of BP was performed in the leptin-deficient ob/ob mice and control animals by radiotelemetry combined with fast Fourier transformation (FFT) before and after both leptin and enalapril treatment. Autonomic function was as well assessed pharmacologically.
Methods

Animals
We studied adult 16-week-old male ob/ob (B6.V-Lepob/J) mice and male ob/+ (C57BL/6J) purchased from Jackson Laboratory (Bar Harbor, ME, USA). The animals were maintained on a 12-h light/12-h dark cycle at 22°C and had free access to standard chow (0.25% sodium, SSNIFF Spezialitäten GmbH, Soest, Germany) and drinking water ad libitum. All experiments were conducted under these conditions. The local council on animal care approved the study according to requirements of the American Physiological Society. We measured body weights at weekly intervals. After recovery, telemetric baseline values were recorded for 3 days followed by enalapril (Sigma; 30 mg/ Kg.day) and by leptin (R&D; 6 μg/day) treatment in Alzet osmotic minipumps for 28 days. Enalapril was given to every mouse in the drinking water for 7 days. A wash out period of 7 days was allowed before osmotic minipumps containing leptin were implanted. After 1 week of leptin infusion, data were collected again.
Pharmacological testing of autonomic function
To evaluate autonomic control of BP, the following drugs were applied: muscarinic blockade was obtained with atropine (2 mg/kg; ob/+, n=8; ob/ob, n=6), β 1 -adrenergic receptor blockade with metoprolol (4 mg/kg; ob/+, n=6; ob/ob, n=5), and ganglionic blockade with trimetaphane (30 mg/kg; ob/+, n=5; ob/ob, n=5). All of the substances were given intraperitoneally in the morning hours between 9:00 and 12:00 a.m. Continuous beat-by-beat values of BP were recorded for 1 h, after which, the drugs were applied. Thereafter, beat-by-beat values were recorded for one additional hour. As in a former study [11] , the values from the 45th to the 60th minute after drug injection were used to characterize the respective responses to avoid the measurement of stress-induced BP and HR changes. The protocols for the single injections were separated by ≥24 h. Drug administrations were not randomized. BP values in this study represent means of 3 days.
Spectral analysis
Our approaches to radiotelemetry, spectral analysis, and calculations of baroreflex sensitivity (BRS) have been described elsewhere [11, 12] . For evaluation of cardiovascular function, the baroreceptor HR reflex and HR variability in the low-frequency range (HRV-LF) were investigated using spontaneous changes in BP and HR. The power spectra of systolic BP (SBP), pulse interval time series, and the cross spectra were calculated using FFT. Beat-to-beat values of detected R-R intervals and BP values were interpolated, low-pass filtered (cutoff 6 Hz), and resampled at 12 Hz. Data segments of 43 s were used for spectral analysis. Linear trends were removed, and power spectral density was estimated with the FFT-based Welch algorithm using segments of 512 data points with 50% overlapping and Hanning window. The power in the frequency range of low frequencies (LF, 0.25 to 0.6 Hz) was calculated. Five representative intervals were chosen for spectral analysis and averaged according to the following criteria: (1) steady state conditions, (2) no large sudden BP changes, and (3) no artifacts. The frequency bands were adapted for analysis in mice considering the ranges of HR rate and breathing frequencies [13] .
Baroreflex sensitivity (BRS)
Spontaneous baroreflex slope was calculated as the slope of the linear regression line between SBP and the subsequent R-R intervals using sequences defined as an episode of at least three heartbeats with more than 0.01 mmHg SBP per beat. The average values of all slopes with a correlation coefficient greater than 0.85 were calculated for sequences with rising BP (BRS-up). The BRS-LF was defined as the mean magnitude value of transfer function between SBP and R-R interval in the low-frequency band with negative phase and squared coherence value greater than 0.5. A negative phase indicates that BP leads R-R interval, and a coherence value greater than 0.5 indicates a dominating linear relationship. The data analysis was performed with the PV-wave software (Visual Numerics, Houston, TX, USA).
Statistics
Data are presented as means±SEMs. Statistically significant differences in mean values were evaluated by analysis of variance followed by Bonferroni post hoc test. Unpaired Student t test was used as independent samples. The value of P≤0.05 was considered significant.
Results
Non-dipping arterial hypertension in ob/ob mice
In the beginning of the telemetry measurements, following adaptation and recovery periods after probe implantations, body weight values were higher in ob/ob (58.2±0.7 g) when compared to ob/+ mice (29.4±0.9 g). As previously described [14, 15] , blood glucose levels were increased in ob/ob compared to ob/+ mice at 16 weeks of age. Day and night mean arterial pressure (MAP) and HR are shown in Fig. 1 . Daytime MAP was higher in ob/ob (112.5± 1.2 mmHg) when compared to the controls (104.2± 2.6 mmHg; P<0.05: Fig. 1a) . No difference in BP between the groups was observed during the active night period. Thus, ob/ob mice showed an abnormal diurnal BP dipping status as can be seen by the reduction of the BP amplitude (6.9±0.6 vs. 2.0±0.2 mmHg). On the other hand, HR was not different between the groups at both day and night time and showed a normal diurnal pattern (day, ob/+=484.7±6.8 and ob/ob=511.1±10.2 bpm; night: ob/+=527.6±6.7 and ob/ob=551.6±10.1 bpm; Fig. 1b ).
Autonomic imbalance in ob/ob mice The activity of the autonomic nervous system was tested pharmacologically. BP response to trimetaphane and HR response to both atropine and metoprolol were measured. The ganglionic blockade with trimetaphane reduced BP in both strains (−28.9±0.9 vs. −43.3±2.5 mmHg; Fig. 2a) . However, the effect in obese mice was more pronounced than in controls (P<0.001). A lower HR response to atropine was observed in ob/ob mice compared to ob/+ (102.2±3.6 vs. 64.8±3.6 bpm; P<0.001; Fig. 2b ). β 1 -adrenergic receptor blockade with metoprolol provoked a higher decrease in HR in ob/ob than in ob/+ mice (−37.8±3.0 vs. −97.2±6.0 bpm; P<0.001; Fig. 2c ). These results suggest increased sympathetic and decreased parasympathetic tone in ob/ob mice. Sympathetic modulation of vascular tone was also analyzed by the low-frequency systolic BP (LF-SBP) oscillations, derived from the Fourier analyses of the telemetric BP data [16] . Along with the trimetaphane and metoprolol results, LF-SBP was found increased in ob/ob mice (2.5±0.3 vs. 5.4± 1.1 mmHg 2 ; P<0.05; Fig. 3a) . In mice, low-frequency HR oscillations (LF-HRV) are mediated through parasympathetic mechanisms [17] . In obese mice, LF-HRV was attenuated which corresponds with the decreased response to atropine (4.8±0.9 vs. 1.8±0.6 msec 2 ; P<0.05; Fig. 3b ).
Reduced baroreflex in ob/ob mice
The baroreflex HR regulation was assessed by the sequence method and cross-spectral analysis. We have previously proven the validity of spontaneous BP and HR changes to characterize BRS in conscious mice [12] . BRS-up and BRS-LF were significantly decreased in ob/ob mice. Values for BRS were substantially lower in ob/ob mice (BRS-up=0.36±0.10 msec/ mmHg, Fig. 3c ; BRS-LF=0.79±0.19 msec/mmHg, Fig. 3d ) compared to ob/+ animals (BRS-up=1.09±0.25 msec/mmHg and BRS-LF=1.96±0.47 msec/mmHg; P<0.05). and heart rate (HR; b) for ob/+ (n=6, white bars) and ob/ob (n=7, black bars) mice. MAP was higher in ob/ob mice only during the day. HR was higher in both groups at night (*P<0.05, **P<0.01)
Autonomic imbalance is reversed by chronic leptin treatment
The same parameters were measured after 1 week of leptin treatment with osmotic minipumps. Leptin was given in a concentration (6 µg/day) previously described to restore glucose levels [18] . Leptin levels increased in both groups after 1 week of infusion (normal levels: ob/+=2.2±0.7 and ob/ob=0 vs. after leptin: ob/+=23.1±2.2 and ob/ob=12. Figure 4 shows BP changes after leptin treatment in ob/ ob and control animals. Infusion of leptin decreased BP in ob/ob but not significantly in control mice. After 1 week of leptin treatment, changes in MAP in ob/+ mice was −4.1± 1.6 and −10.5±2.3 mmHg in ob/ob mice (P<0.05). Leptin also increased baroreflex in both strains. Moreover, in leptin-treated ob/ob mice, BRS was restored to the values of ob/+ (BRS-LF: ob/+ before leptin: 1.9±0.5 vs. ob/ob after leptin 2.5±0.5; Fig. 3d ). LF-SBP was not changed after leptin treatment in the control animals. However, the increased LF-SBP observed in ob/ob mice was normalized by leptin (ob/+ baseline vs. ob/ob+ leptin: 2.5±0.3 vs. 1.8± 0.7 mmHg 2 ; Fig. 3a ). Complete interruption of efferent autonomic traffic with trimetaphane resulted in a more pronounced reduction of BP in ob/ob mice during baseline, as shown in Fig. 2a . After leptin treatment, the effect of trimetaphane in obese animals was restored to the control baseline levels (ΔBP ob/+ baseline vs. ob/ob+ leptin: −28.9±0.9 vs. −24.2±1.2 mmHg).
Autonomic imbalance is reversed by angiotensin-converting enzyme (ACE) inhibition Figure 5a shows the MAP changes during treatment with the angiotensin-converting enzyme (ACE) inhibitor enalapril, which had no effect on body weight. Enalapril reduced MAP in all animals and normalized circadian rhythm of BP in ob/ob mice. Furthermore, it significantly increased BRS-LF and LF-HRV and decreased LF-SBP (Fig. 5b-d) . In contrast, these parameters did not change significantly in control animals after treatment with enalapril. 
Discussion
The major phenotypes of leptin-deficient ob/ob mice are insulin resistance and obesity [19] . Often, obesity is accompanied by a greater blood volume and increased cardiac output, which may lead to the development of hypertension [20] . This sequence of events may be the cause for the observed tight association between obesity and hypertension in most populations and suggests involvement of an adipose tissue-derived signal [21] [22] [23] . Leptin is the prime suspect because it was shown to elicit sympathetic activation when injected at high doses directly into the brain [24] [25] [26] . Indeed, circulating leptin concentrations are increased in patients with obesity and type 2 diabetes [27, 28] . Leptin levels are also augmented in nondiabetic patients with hypertension [29, 30] . Furthermore, mice that overexpress leptin have elevated tail-cuff systolic BP [31] .
However, we have recently shown that the db/db mice, a model deficient in the major leptin receptor, exhibit elevated BP associated with increased sympathetic and attenuated parasympathetic drive compared to the control littermates [8] . Nevertheless, the db/db mice express other isoforms of leptin receptors and exhibit high circulating leptin levels. Thus, the well-described leptin-induced sympathoactivation may be involved in the cardiovascular autonomic dysfunction observed in the db/db mice employing other receptors.
To clarify this issue, we analyzed the cardiovascular regulation in ob/ob mice completely lacking leptin. In our hands, ob/ob mice had slightly but significantly higher BP compared to the control littermates during the day. The published results about both acute and chronic BP measurements in ob/ob mice appear to be controversial. In several studies, BP was evaluated 48 h after surgery, a time frame not sufficient for stabilizing BP and day/night circadian rhythm. In contrast to previous findings but more according to our data, Swoap reported slightly increased BP in ob/ob mice with levels of 108±2 compared with 100±2 mmHg in controls [32] . In that study, BP was also measured by telemetry like in ours. However, the telemetric devices were implanted into the aorta through the carotid artery which may have impaired the function of the carotid baroreceptors. For that reason and because our study focused on the autonomic regulation of BP in the ob/ob mice, we implanted the telemetric device through the femoral artery.
Similar to what we found in the leptin receptor-deficient db/db mice, BP failed to drop during the inactive period in the ob/ob mice, a pattern that resembles non-dipping of BP often seen in hypertensive humans [33] . A disturbed circadian rhythm is often associated with metabolic disorders [34] . The Clock mutant mice, which lack a transcription factor involved in the generation of circadian rhythms, are hyperphagic and develop obesity. The resultant obesity is associated with increased blood glucose, cholesterol, and triglyceride levels, as observed in obese humans with metabolic syndrome [35] . Additionally, reduced circadian BP variation is associated with increased mortality [36] .
More importantly, we observed an imbalance of the autonomic nervous system in the ob/ob mice. Regardless of the total absence of leptin, a higher sympathetic tone was unexpectedly found in these animals. Although no direct measurements of sympathetic activity was performed, the stronger effect of metoprolol and trimetaphane in the ob/ob mice support that notion. Along with these findings, the parameter LF-SBP, which is believed to represent the sympathetic tone to the periphery, was found increased in the ob/ob animals.
In a previous work, we underscored the validity of spontaneous BP and HR changes to characterize BRS in conscious mice [12] , as shown previously in humans [37] . Baroreflex is attenuated in the ob/ob mice as can be seen by a reduction of BRS-up and BRS-LF. Vagal regulation is also reduced in the obese animals. HR increase in response to intraperitoneal injection of atropine was approximately 40% reduced in the ob/ob compared to the control mice. In keeping with that finding, LF-HRV was found attenuated in the obese mice. Altogether, our data shows that ob/ob mice at 16 weeks of age present alterations of the autonomic homeostatic mechanisms that regulate BP and HR.
Chronic infusion of leptin reduced BP in our ob/ob mice probably by reducing sympathetic activity to the periphery. Accordingly, leptin infusion reduced the trimetaphane effect on BP and LF-SBP in ob/ob mice to the baseline level of control animals and normalized the altered baroreflex in these animals. Such reduction in BP by leptin has already been described in rats after intracerebroventricular infusion of the protein at low doses [38] . Taken together, our results suggest that leptin is not involved in the onset and maintenance of neither the obesity-related hypertension nor the autonomic dysfunction related to type 2 diabetes. In the opposite, the resistance to leptin often observed in obese and diabetic patients [39] may even be causal for the increased BP in analogy to the ob/ob and db/db mice.
In contrast, the renin-angiotensin system seems to be involved in this phenotype. Angiotensin II regulates BP via peripheral and central mechanisms. Centrally, angiotensin II activates the sympathetic nervous system. Furthermore, angiotensin II alters baroreflex HR regulation. We analyzed the inhibition of ACE by enalapril in the ob/ob mouse model, since we had found increased ACE activity in db/db mice, which was later confirmed in another study [40] . ACE inhibition decreased BP in both groups and normalized the circadian rhythm in ob/ob mice suggesting that the increase in BP was at least in part due to the renin-angiotensin system in this model. The associated improvement of BRS and reducing sympathetic drive to the periphery by enalapril is consistent with a central mechanism. Markedly, inhibition of ACE had similar effects as leptin treatment in obese mice. Nevertheless, enalapril treatment did not change body weight in both groups excluding the possibility that weight loss could influence and restore autonomic dysfunction.
Our results show that BP in the leptin-deficient ob/ob mice is associated to an imbalance of the autonomic nervous system featured by sympathetic activation and reduction of the parasympathetic tone in association with diminished BRS. Therefore, we conclude that ob/ob mice, like db/db mice [8] , are a model for the cardiovascular autonomic neuropathy seen in diabetic and obese patients [24, 25, 41] predisposing them to target organ damage and cardiac arrhythmias and ultimately increasing morbidity and mortality.
In conclusion, our data suggest that angiotensin II is involved in the autonomic imbalance associated with obesity and hypertension caused by leptin deficiency.
Perspectives
Our data suggest that the renin-angiotensin system, but not leptin, is involved in non-dipping hypertension and autonomic imbalance related to obesity, and type 2 diabetes may have experimental and clinical implications. Possibly the leptin resistance observed in patients is involved in the BP increase accompanying metabolic syndrome and obesity since we have unexpectedly shown that leptin reduces sympathetic activity and BP at least in ob/ob mice. Pharmacological activation of the leptin system or breaching of leptin resistance could, therefore, not only ameliorate obesity but also improve cardiovascular parameters. In addition, our data underscore the suitability of the RAS as drug target in the human metabolic syndrome.
